Table 1.
Infections, No. | ||
---|---|---|
Infection Type and Classification Group | CAB Arm (n= 4) | TDF/FTC Arm (n = 36) |
Baseline | 1 | 0 |
HIV positive at study enrollment | Case A1 | |
Incident | 3 | 36 |
No recent CAB exposure | Cases B1 and B2 | |
Infected during the CAB injection phase | Case DX | |
Inconsistent/poor TDF/FTC adherence | Cases E1-E35 | |
Partial TDF/FTC adherence | Case E36 |
Abbreviations: CAB, cabotegravir; FTC, emtricitabine; HIV, human immunodeficiency virus; TDF, tenofovir disoproxil fumarate.
This table shows the system used to classify cases in the CAB and TDF/FTC arms. Groups were assigned based on study arm and timing of HIV infection/exposure to study drug. Each case was assigned a group letter and a case number (eg, case A1). Cases in the TDF/FTC arm are numbered based on the number of days between study enrollment and the first HIV-positive visit, from the longest (846 days [case E1] ) to the shortest (12 days [case E36]) interval.